Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Amyotrophic lateral sclerosis | 14 | 3 | |
General health | 9 | 4 | |
Support immune health | 8 | 6 | |
Primary lateral sclerosis | 2 | 7 | |
Brain fog | 1 | 0 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 0 | |
Moderate | 0 | |
Mild | 0 | |
None | 17 |